Training Europe's Psychedelic Therapy Experts

Pan-European Network | 16 Doctoral Candidates |
20+ Partners | 9 Countries | 2026-2030

We are a multidisciplinary, multi-sectoral EU MSCA Doctoral Network for training and educating future leaders and experts in implementation of psychedelic therapy for the treatment of depression in society and healthcare.

For people living with severe depression or PTSD, the search for lasting relief can feel endless.
Psychedelic therapy (PT) offers new hope, but it’s still surrounded by unanswered questions and difficult to access.

1 in 8 people

globally have a mental disorder

2.5 trillion USD

annual societal cost worldwide

20-60%

don't respond to existing treatments

Zero

EMA-approved medicines in 2021; no real innovation in decades

Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics

Supported by the EU Marie Skłodowska-Curie Actions programme, the INTEGRATE project will train a new generation of doctoral researchers to explore how psychedelic therapy (PT) works, set clinical standards, and address legal and ethical barriers.

Working closely with universities, healthcare providers and industry, INTEGRATE is preparing skilled professionals to bring safe, effective PT into real-world mental health care, offering new hope to those who need it most.

Objective

Through interdisciplinary research, training, and collaboration, INTEGRATE aims to advance psychedelic science, optimize treatment protocols, and address ethical and regulatory challenges to improve mental healthcare. It addresses the urgent need for well-trained experts to navigate the complex landscape of PT in healthcare.

Method

The project will train 16 Doctoral Candidates (DCs) to become T-shaped professionals, equipped with deep disciplinary knowledge and broad interdisciplinary skills. Through collaborative research, innovative training, and strategic secondments, INTEGRATE will tackle the key challenges in PT research with matching research and innovation objectives.

Four key challenges

Each of the four key challenges in implementing psychedelic therapy in mental health care is addressed in the INTEGRATE work packages.

1 Understanding the mechanisms of psychedelic therapy

Although the evidence is clear, it is still unknown via what mechanisms psychedelic therapy can heal the mind. INTEGRATE aims to uncover the science behind it.

2 Setting Clinical Standards

Currently, there is no standardized playbook for implementing psychedelic therapy in a medical setting. INTEGRATE will create gold-standard protocols for safe, effective care.

3 Legal, financial, and regulatory obstacles for PT access

Legal, financial, and regulatory hurdles need to be resolved to implement psychedelic therapy. INTEGRATE maps pathways for fair and responsible integration.

4 Hype, hope, and ethical challenges

From stigma to hype, the conversation about psychedelic therapy needs balance. INTEGRATE investigates and promotes ethical practice and honest communication.